[Federal Register Volume 87, Number 20 (Monday, January 31, 2022)]
[Notices]
[Pages 4891-4893]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-01826]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[60Day-22-0978; Docket No. CDC-2022-0012]


Proposed Data Collection Submitted for Public Comment and 
Recommendations

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice with comment period.

-----------------------------------------------------------------------

SUMMARY: The Centers for Disease Control and Prevention (CDC), as part 
of its continuing effort to reduce public burden and maximize the 
utility of government information, invites the general public and other 
federal agencies the opportunity to comment on a proposed and/or 
continuing information collection, as required by the Paperwork 
Reduction Act of 1995. This notice invites comment on a proposed 
information collection project titled Emerging Infections Program 
(EIP). EIP is a population-based surveillance system designed to 
collect information via active, laboratory case finding that is used 
for detecting, identifying, and monitoring emerging pathogens.

DATES: CDC must receive written comments on or before April 1, 2022.

ADDRESSES: You may submit comments, identified by Docket No. CDC-2022-
0012 by either of the following methods:
     Federal eRulemaking Portal: Regulations.gov. Follow the 
instructions for submitting comments.
     Mail: Jeffrey M. Zirger, Information Collection Review 
Office, Centers for Disease Control and Prevention, 1600 Clifton Road 
NE, MS H21-8, Atlanta, Georgia 30329.
    Instructions: All submissions received must include the agency name 
and Docket Number. CDC will post, without change, all relevant comments 
to Regulations.gov.
    Please note: Submit all comments through the Federal eRulemaking 
portal (regulations.gov) or by U.S. mail to the address listed above.

FOR FURTHER INFORMATION CONTACT: To request more information on the 
proposed project or to obtain a copy of the information collection plan 
and instruments, contact Jeffrey M. Zirger, Information Collection 
Review Office, Centers for Disease Control and Prevention, 1600 Clifton 
Road NE, MS H21-8, Atlanta, Georgia 30329; phone: 404-639-7570; Email: 
[email protected].

SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995 
(PRA) (44 U.S.C. 3501-3520), federal agencies must obtain approval from 
the Office of Management and Budget (OMB) for each collection of 
information they conduct or sponsor. In addition, the PRA also requires 
federal agencies to provide a 60-day notice in the Federal Register 
concerning each proposed collection of information, including each new 
proposed collection, each proposed extension of existing collection of 
information, and each reinstatement of previously approved information 
collection before submitting the collection to the OMB for approval. To 
comply with this requirement, we are publishing this notice of a 
proposed data collection as described below.
    The OMB is particularly interested in comments that will help:
    1. Evaluate whether the proposed collection of information is 
necessary for the proper performance of the functions of the agency, 
including whether the information will have practical utility;
    2. Evaluate the accuracy of the agency's estimate of the burden of 
the proposed collection of information,

[[Page 4892]]

including the validity of the methodology and assumptions used;
    3. Enhance the quality, utility, and clarity of the information to 
be collected;
    4. Minimize the burden of the collection of information on those 
who are to respond, including through the use of appropriate automated, 
electronic, mechanical, or other technological collection techniques or 
other forms of information technology, e.g., permitting electronic 
submissions of responses; and
    5. Assess information collection costs.

Proposed Project

    Emerging Infections Program (EIP) (OMB Control No. 0920-0978, Exp. 
4/30/2022)--Revision--National Center for Emerging and Zoonotic 
Infectious Diseases (NCEZID), Centers for Disease Control and 
Prevention (CDC).

Background and Brief Description

    The Emerging Infections Programs (EIPs) are population-based 
centers of excellence established through a network of state health 
departments collaborating with academic institutions; local health 
departments; public health and clinical laboratories; infection control 
professionals; and healthcare providers. EIPs assist in local, state, 
and national efforts to prevent, control, and monitor the public health 
impact of infectious diseases.
    Activities of the EIPs fall into the following general categories: 
(1) Active surveillance; (2) applied public health epidemiologic and 
laboratory activities; (3) implementation and evaluation of pilot 
prevention/intervention projects; and (4) flexible response to public 
health emergencies. Activities of the EIPs are designed to: (1) Address 
issues that the EIP network is particularly suited to investigate; (2) 
maintain sufficient flexibility for emergency response and new problems 
as they arise; (3) develop and evaluate public health interventions to 
inform public health policy and treatment guidelines; (4) incorporate 
training as a key function; and (5) prioritize projects that lead 
directly to the prevention of disease.
    A Revision is being submitted to make existing collection 
instruments clearer and to add several new forms specifically surveying 
laboratory practices. These forms will allow the EIP to better detect, 
identify, track changes in laboratory testing methodology, gather 
information about laboratory utilization in the EIP catchment area to 
ensure that all cases are being captured, and survey EIP staff to 
evaluate program quality.
    CDC requests OMB approval for an estimated burden of 61,956 hours. 
There is no cost to respondents other than their time.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                     Number of      Avg. burden
      Type of respondent            Form name        Number of     responses per   per response    Total burden
                                                    respondents     respondent      (in hours)      (in hours)
----------------------------------------------------------------------------------------------------------------
State Health Department.......  ABCs Case Report              10             809           20/60           2,697
                                 Form.                        10             127           10/60             212
                                ABCs Invasive
                                 Pneumococcal
                                 Disease in
                                 Children and
                                 Adults Case
                                 Report Form.
                                ABCs H.                       10               6           10/60              10
                                 influenzae
                                 Neonatal Sepsis
                                 Expanded
                                 Surveillance
                                 Form.
                                ABCs Severe GAS               10             136           20/60             453
                                 Infection
                                 Supplemental
                                 Form.
                                ABCs Neonatal                 10              37           20/60             123
                                 Infection
                                 Expanded
                                 Tracking Form.
                                FoodNet                       10             970           21/60           3,395
                                 Campylobacter.
                                FoodNet                       10              42           10/60              70
                                 Cyclospora.
                                FoodNet Listeria              10              16           20/60              53
                                 monocytogenes.
                                FoodNet                       10             855           21/60           2,993
                                 Salmonella.
                                FoodNet Shiga                 10             290           20/60             967
                                 toxin producing
                                 E. coli.
                                FoodNet Shigella              10             234           10/60             390
                                FoodNet Vibrio..              10              46           10/60              77
                                FoodNet Yersinia              10              55           10/60              92
                                FoodNet                       10              10               1             100
                                 Hemolytic
                                 Uremic Syndrome
                                 Case Report
                                 Form.
                                FoodNet Clinical              10              70           20/60             233
                                 Laboratory
                                 Practices and
                                 Testing Volume.
                                FluSurv-NET                   10             764           25/60           3,183
                                 Influenza
                                 Hospitalization
                                 Surveillance
                                 Network Case
                                 Report Form.
                                FluSurv-NET                   10             333            5/60             278
                                 Influenza
                                 Hospitalization
                                 Surveillance
                                 Project
                                 Vaccination
                                 Phone Script
                                 Consent Form
                                 (English).
                                FluSurv-NET                   10             333            5/60             278
                                 Influenza
                                 Hospitalization
                                 Surveillance
                                 Project
                                 Vaccination
                                 Phone Script
                                 (Spanish).
                                Influenza                     10             333            5/60             278
                                 Hospitalization
                                 Surveillance
                                 Project
                                 Provider
                                 Vaccination
                                 History Fax
                                 Form (Children/
                                 Adults).
                                FluSurv-NET                   10              16           10/60              26
                                 Laboratory
                                 Survey.

[[Page 4893]]

 
                                HAIC--MuGSI Case              10             500           28/60           2,333
                                 Report Form for
                                 Carbapenem-
                                 resistant
                                 Enterobacteriac
                                 eae (CRE) and
                                 Acinetobacter
                                 baumannii
                                 (CRAB).
                                HAIC--MuGSI                   10            4200           25/60          17,500
                                 Extended-
                                 Spectrum Beta-
                                 Lactamase-
                                 Producing
                                 Enterobacteriac
                                 eae (ESBL/iEC).
                                HAIC--Invasive                10             340           28/60           1,587
                                 Methicillin-
                                 resistant
                                 Staphylococcus
                                 aureus (MRSA)
                                 Infection Case
                                 Report Form.
                                HAIC--Invasive                10             584           28/60           2,725
                                 Methicillin-
                                 sensitive
                                 Staphylococcus
                                 aureus (MSSA)
                                 Infection Case
                                 Report Form.
                                HAIC--CDI Case                10            1650           38/60          10,450
                                 Report and
                                 Treatment Form.
                                HAIC Candidemia               10             200           30/60           1,134
                                 Case Report.
                                HAIC--Annual                  10              16           19/60              51
                                 Survey of
                                 Laboratory
                                 Testing
                                 Practices for
                                 C. difficile
                                 Infections.
                                HAIC--CDI Annual              10               1           15/60               3
                                 Surveillance
                                 Officers Survey.
                                HAIC--Emerging                10              45            5/60              38
                                 Infections
                                 Program C.
                                 difficile
                                 Surveillance
                                 Nursing Home
                                 Telephone
                                 Survey (LTCF).
                                HAIC--Invasive                10              11           20/60              37
                                 Staphylococcus
                                 aureus
                                 Laboratory
                                 Survey.
                                HAIC--Invasive                10               1           10/60              17
                                 Staphylococcus
                                 aureus
                                 Supplemental
                                 Surveillance
                                 Officers Survey.
                                HAIC--Laboratory              10              20           12/60              40
                                 Testing
                                 Practices for
                                 Candidemia
                                 Questionnaire.
                                HAIC MuGSI CA CP-            100              10           30/60              50
                                 CRE Health
                                 interview (new).
                                HAIC MuGSI                    10               1           15/60               3
                                 Supplemental
                                 Surveillance
                                 Officer Survey
                                 (new).
                                HAIC Death                    10               8         1440/60          10,080
                                 Ascertainment
                                 Variables.
                                                 ---------------------------------------------------------------
    Total.....................  ................  ..............  ..............  ..............          61,956
----------------------------------------------------------------------------------------------------------------


Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific 
Integrity, Office of Science, Centers for Disease Control and 
Prevention.
[FR Doc. 2022-01826 Filed 1-28-22; 8:45 am]
BILLING CODE 4163-18-P